Co-overexpression of Bag-1 and heat shock protein 70 in human epidermal squamous cell carcinoma: Bag-1-mediated resistance to 5-fluorouracil-induced apoptosis by Wood, J et al.
Co-overexpression of Bag-1 and heat shock protein 70 in human
epidermal squamous cell carcinoma: Bag-1-mediated resistance to
5-fluorouracil-induced apoptosis
J Wood
1, M Pring
1, JW Eveson
1, N Price
1, CM Proby
2 and A Hague*,1
1School of Oral and Dental Science, University of Bristol, Lower Maudlin Street, Bristol BS1 2LY, UK;
2Skin Tumour Laboratory, Wellcome Centre for
Molecular Medicine, PO Box 11, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK
BACKGROUND: The aim was to determine whether Bcl-2-associated athanogene-1 (Bag-1) and/or its binding protein heat shock
protein-70 (Hsp70) exhibit deregulated expression in epidermal squamous cell carcinoma (SCC) and whether Bag-1 confers
apoptosis resistance.
METHOD: Immunohistochemistry for Bag-1 and Hsp70 was performed on 60 epidermal SCC and 10 normal skin samples. The
epidermal SCC cell line SCC-13 was treated with 5-fluorouracil (5-FU) after Bag-1 knockdown to determine whether high
Bag-1 levels contribute to growth and/or apoptosis resistance.
RESULTS: Normal epithelium expressed primarily nuclear Bag-1. Most tumours showed reduced nuclear Bag-1 staining, but a subset
exhibited strong Bag-1 staining, with cytoplasmic Bag-1 staining intensity correlating with cytoplasmic Hsp70 staining intensity
(rs¼0.462; Po0.001) and less differentiation (Po0.001). Bag-1 knockdown resulted in markedly reduced SCC-13 cell yield,
increased spontaneous apoptosis and enhanced sensitivity to 5-FU-induced apoptosis. Apoptosis induced by 5-FU in the
Bag-1-knockdown cells was significantly greater than the additive apoptotic effect of 5-FU or Bag-1 knockdown alone.
CONCLUSIONS: Overexpression of Bag-1 and Hsp70 in poorly differentiated SCC may confer both enhanced tumour cell growth and
apoptosis resistance. Bag-1 may contribute to the resistance of more advanced epidermal SCC to chemotherapy.
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Bcl-2-associated athanogene-1 (Bag-1) expression is deregulated in
a variety of human tumours, including cancers of the breast, lung,
colon, oesophagus, larynx, oral cavity and tongue (reviewed by
Wood et al, 2009). The Bag-1 protein was first identified because of
the interaction with Bcl-2, and was shown to enhance Bcl-2-
mediated cell survival (Takayama et al, 1995). Bag-1 interacts with
various cellular proteins in addition to Bcl-2, including Raf-1 and
B-Raf (Wang et al, 1996; Go ¨tz et al, 2005), retinoblastoma protein
(Arhel et al, 2003), GADD34 (Hung et al, 2003), growth factor
receptors (Bardelli et al, 1996), nuclear receptors (Zeiner and
Gehring, 1995), heat shock proteins (Hsps) Hsc70 and Hsp70
(Ho ¨hfeld and Jentsch, 1997; Zeiner et al, 1997), the proteasome
(Lu ¨ders et al, 2000) and E3 ligases, Siah-1 (Matsuzawa et al, 1998)
and CHIP (Alberti et al, 2002).
Bag-1 expression is deregulated in oral squamous cell carcinoma
(SCC), with increased expression associated with progression,
metastasis and poor prognosis in early stage tumours (Shindoh
et al, 2000) and increased cytoplasmic Bag-1 in lymph node
metastases (Hague et al, 2002). Bag-1 has been implicated as a
prognostic marker in oral SCC, showing correlation with over-
expression of Bcl-2 (Xie et al, 2004) and Hsp70 (Weber et al, 2007).
Three major Bag-1 isoforms are expressed in human cells, Bag-1S,
Bag-1M and Bag-1L, with molecular sizes of 36, 46 and 50kDa,
respectively. Some tissues and tumour cells express a fourth Bag-1
isoform, 29kDa in size (Townsend et al, 2003a). Although Bag-1L
is predominantly nuclear, Bag-1M and Bag-1S partition between
cytoplasm and nucleus (Yang et al, 1998). Relocalisation to the
nucleus at 2h after heat shock has been shown for Bag-1M in HeLa
cells (Zeiner et al, 1999) and Bag-1S in MCF-7 breast cancer cells
(Townsend et al, 2003b). By contrast, in colorectal tumour cells
Bag-1M exited the nucleus 24h after g-irradiation (Barnes et al,
2005). Moreover, overexpression of nuclear Bag-1L conferred
protection against apoptosis in response to g-irradiation and the
vitamin D analogue, EB1089 (Barnes et al, 2005). Together, these
findings indicate a nuclear site of action for the anti-apoptotic
function of Bag-1. Nuclear anti-apoptotic functions can be
mediated by Bag-1 interaction with Hsp70 (Townsend et al,
2003b).
Hsp70/Hsc70 interactions with Bag-1 may also be required for
an anti-apoptotic function in the cytoplasm. In cardiac myocytes,
Bag-1S and Bag-1M, but not Bag-1L, were protective against
apoptosis following simulated ischemia–reperfusion injury
(Townsend et al, 2004). Bag-1S with point mutations in the
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protection. The requirement for a cytoplasmic localisation for the
anti-apoptotic effect of Bag-1 was demonstrated by the over-
expression of Bag-1S tagged with a nuclear localisation sequence
(localised entirely in the nucleus) which failed to protect against
apoptosis (Townsend et al, 2004). Bag-1 protects against apoptosis
induced by various other stimuli including Fas signalling
(Takayama et al, 1995), growth factor withdrawal (Clevenger
et al, 1997), hypoxia (Ishioka et al, 2007) and cytotoxic drugs
(Chen et al, 2002). Studies indicating a role for Hsp70 binding as a
mechanism for Bag-1 anti-apoptotic function suggest that co-
expression of these proteins may facilitate increased resistance to
apoptosis in cancer, with potential implications for treatment, such
as acquisition of resistance to chemotherapeutic drugs.
Non-melanoma skin cancer has a rapidly increasing incidence,
the main aetiological agent being ultraviolet B (UVB) radiation, a
complete carcinogen (Assefa et al, 2005). Non-melanoma skin
cancer is the most common human cancer, with B100000 new
cases diagnosed per year in the United Kingdom, of which around
20% are SCC (source: Cancer Research UK). In particular, patients
taking immunosuppressive drugs have a 100-fold higher risk of
developing cutaneous SCC, which is specific to sun exposed skin
areas (Lindelo ¨f et al, 2000). Sun exposure-induced skin cancers
frequently show ‘UV-signature’ CC to TT base transition mutations
in the p53 gene (Boukamp, 2005). p53 gain-of-function mutants
have previously been shown to upregulate Bag-1 expression (Yang
et al, 1999) and a correlation between Bag-1 and p53 expression has
been shown in breast cancer (Tang et al, 2004). Surgery is successful
in treating most SCCs, but radiotherapy and chemotherapy are also
used. Chemotherapy creams containing 5-fluorouracil (5-FU) are
used to treat actinic keratosis, a pre-malignant lesion, and Bowen’s
disease (SCC in situ; Moore, 2009; Micali et al,2 0 1 0 ) .5 - F Ui sa n
anti-metabolite, which is converted to fluorouridine monopho-
sphate, inhibiting thymidylate synthase and hence interfering with
DNA synthesis, as well as being further metabolised to uridine
analogues that are incorporated into RNA and DNA. The resultant
cellular responses are growth inhibition and cell death. As actinic
keratoses occur on sun-exposed skin and patients typically have
multiple lesions, often on the face, 5-FU ointments are favoured
over surgery to treat the field. They are also used on digits to
preserve mobility (Moore, 2009).
Although in oral epithelium, the spontaneous frequency of
apoptosis is very low (Hague et al, 2004), in epidermis there is a
very high rate of apoptosis at sun-exposed sites and overactive
survival pathways may contribute to tumourigenesis in the skin
(Lippens et al, 2009). However, there are no currently published
studies investigating the expression of the anti-apoptotic proteins
Bag-1 or Hsp70 in epidermal SCC. Here we used an immunohis-
tochemical study of human epidermal SCC to determine whether
Bag-1 and/or Hsp70 expression was altered during squamous cell
carcinogenesis of the skin, and whether Bag-1 expression was
related to Hsp70 or p53 staining. There are no reports of whether
Bag-1 protects against apoptosis in epidermal SCC and whether
Bag-1 might affect response to therapy. Therefore, we used 5-FU as
an apoptotic stimulus and a Bag-1 knockdown approach to
determine whether the high levels of Bag-1 expressed in the
epidermal SCC cell line SCC-13 contribute to apoptosis resistance.
MATERIALS AND METHODS
Tissues, antibodies and siRNA
Formalin-fixed, paraffin-embedded tissue from epidermal SCC
(60) and normal epidermis overlying an epidermoid cyst (10) was
used (local ethics committee approval: 07/H0104/72). Patient and
SCC characteristics are summarised in Table 1. Antibodies used
were rabbit polyclonal antibody (TB3) raised against a Bag-1-GST
fusion protein (Packham et al, 1997; kind gift from G Packham,
University of Southampton), mouse monoclonal anti-Hsp70 anti-
body (SMC-100, clone C92F3A-5, StressMarq Biosciences Inc., York,
UK) and mouse monoclonal anti-human p53 antibody (BP53-12,
Novocastra Laboratories Ltd, Newcastle, UK). For Bag-1-knock-
down experiments, a Silencer control siRNA (ID #4635) and three
siRNAs specific for Bag-1 mRNA were used: ID #5063 targets exon 2,
ID #5156 targets exons 2 and 3 and ID #147325 targets exon 4
(Ambion, Applied Biosciences Europe, Warrington, UK).
Immunohistochemistry
Tissue sections (2mm) were mounted on poly-lysine coated slides
and incubated overnight at 371C, deparaffinised in xylene,
rehydrated in a decreasing ethanol series, then rinsed in distilled
water. Antigen retrieval was carried out by microwaving (25min at
800W in 1l of citrate buffer, pH 6.0). Endogenous peroxidase
activity was blocked for 15min in 3% (v/v) hydrogen peroxide in
distilled water. Slides were incubated with anti-Bag-1, Hsp70 or
p53 primary antibody (1:1000, 1:50 and 1:50, respectively, in
phosphate-buffered saline (PBS), pH 7.2, containing 1% normal
goat serum (NGS)) at room temperature for 1h. Antibody binding
was detected using Super Sensitive Link-label IHC detection
system (BioGenex, San Ramon, CA, USA). Diaminobenzidine
peroxidase substrate (Dako North America Inc., Carpinteria, CA,
USA) was applied for 6min, followed by washing in distilled water
and a 40s Mayer’s haematoxylin counterstain. Sections were
dehydrated using ethanol, cleared in xylene and mounted using
DPX mountant (Fisher Scientific Ltd, Loughborough, UK).
Negative controls (1% NGS alone) were included in each
staining run. Specificity of Bag-1 recognition by TB3 antibody was
confirmed using antiserum depleted of Bag-1 antibody by pre-
adsorption with GST–Bag-1 protein. In addition, the HaCaT skin
keratinocyte cell line was transfected at 30% confluence with a trio
of siRNAs specific for the Bag-1 mRNA (10nM each; 30nM total) or
with Silencer control siRNA (30nM) in Opti-MEM medium
(Invitrogen, Carlsbad, CA, USA) with Oligofectamine (Invitrogen).
At 72h post transfection, cells were fixed using formal saline,
paraffin-embedded and stained with TB3 antibody.
Table 1 Details of the skin squamous cell carcinoma patients used to
investigate Bag-1 and Hsp70 expression
Test parameter Category Cases Total cases
Gender Male 41
Female 19 60
Age at diagnosis (years) Under 60 2
60–70 8
71–80 27
81–90 16
91–100 7 60
Site of tumour Face/scalp 24
Back/neck/shoulder 7
Ear 9
Leg 8
Arm/hand 8
Other/not recorded 4 60
Tumour size (T) T1 (o20mm) 44
T2 (420 and o50mm) 4
T3 (450mm) 0
Not recorded 12 60
Differentiation Well 33
Moderate 21
Poor 6 60
Abbreviations: Bag-1¼Bcl-2-associated athanogene-1; Hsp70¼heat shock
protein-70.
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Normal epidermal keratinocytes Normal epidermal keratinocytes
(derived from human breast skin) were cultured on 3:1 Dulbecco’s
modified Eagles medium (DMEM): Ham’s F12 (Invitrogen, Paisley,
UK) with 10% fetal bovine serum (FBS; Autogen Bioclear, Wiltshire,
UK), 0.5mgml
 1 hydrocortisone, 10
 10M cholera toxin, 5mgml
 1
transferrin, 2 10
 11Ml i o t h y r o n i n e( a l lf r o mS i g m a - A l d r i c h ,
Gillingham, Dorset, UK), 5mgml
 1 insulin and 10ngml
 1 human
recombinant EGF (Promega, Southampton, Hampshire, UK) in the
presence of mitomycin C-treated Swiss 3T3 feeders.
HaCaT cells The spontaneously immortalised HaCaT epidermal
keratinocyte cell line, which harbours UV-typical p53 gene mutation
(Boukamp et al, 1988) was used for Bag-1-knockdown experiments
to validate the specificity of the TB3 Bag-1 antibody. HaCaT cells
were cultured on 1:1 DMEM:Ham’s F12 (Biowhittaker Lonza,
Verviers, Belgium) with 10% FBS and 0.5mgml
 1 hydrocortisone.
Squamous cell carcinoma cell lines The PM1, PM3, MET2 and
MET4 cell lines were all derived from a 45-year-old male renal
transplant recipient (Proby et al, 2000). These cell lines were
extensively tested for human papillomavirus and were shown to be
negative using a PCR-based method designed to detect all known
cutaneous, epidermodysplasia verruciformis and mucosal HPV types
with a high sensitivity equivalent to 0.05 HPV genome copies per cell
(Proby et al, 2000). The MET2 and MET4 cell lines have a set of
common translocations, suggesting common origin, and have wild-
type ras genes (Popp et al, 2000). PM1 and PM3 were derived from
dysplastic adult forehead skin and are non-tumourigenic, whereas
MET2 was derived from a recurrence of SCC on the back of the hand,
and MET4 from metastatic SCC within the left axillary lymph nodes
(Proby et al,2 0 0 0 ) .P C Rf o re x o n s5–8o ft h ep53 gene did not reveal
any mutations (Popp et al 2000), however, MET2 has recently been
found to have a homozygous p53 mutation resulting in amino acid
change V216M, which may have resulted from expansion of a mutant
p53 cell population in vitro (Andrew South, University of Dundee,
personal communication). SCC-12 and SCC-13 are derived from facial
epidermal SCCs. SCC-12 was from a 60-year-old male renal transplant
patient and SCC-13 was from a 56-year-old female patient who had
received a series of radiation treatments for the tumour several years
before its surgical removal (Rheinwald and Beckett, 1981). SCC-12 has
a V216G and SCC-13 has a Q258K p53 mutation (Burns et al, 1993).
BICR19 was derived from an SCC of the ear of a 69-year-old male and
has a p53 mutation (exon 10 deletion) and expresses in addition a
normal p53 allele (Burns et al,1 9 9 3 ;E d i n g t o net al, 1995; Ken
Parkinson, Queen Mary, Universi t yo fL o n d o n ;K e i t hH u n t e r ,
University of Sheffield, personal communication). The PM1, PM3,
MET2 and MET4 were cultured on 3:1 DMEM: Ham’s F12 with 10%
FBS, 0.5mgml
 1 hydrocortisone, 10
 10Mc h o l e r at o x i n ,5 mgml
 1
transferrin, 2 10
 11M liothyronine, 5mgml
 1 insulin and 10ngml
 1
human recombinant EGF in the presence of mitomycin C-treated
Swiss 3T3 feeders. The SCC-12, SCC-13 and BICR19 cell lines were
cultured on DMEM with 10% FBS and 0.5mgml
 1 hydrocortisone. To
compare the levels of Bag-1, all cell lines were transferred onto 3T3
conditioned dishes in 3T3 conditioned medium consisting of 3:1
DMEM: Ham’s F12 with 10% FBS, with supplements added after
conditioning: 0.5mgml
 1 hydrocortisone, 10
 10 M cholera toxin,
5mgml
 1 transferrin, 2 10
 11 M liothyronine and 5mgml
 1 insulin.
Cells were cultured until B50% confluent (typically 3–4 days) before
harvest for western blotting.
Bag-1 knockdown and 5-FU treatment in the SCC-13 cell
line
The SCC-13 cell line was treated with 5-FU in DMEM with 10% FBS
and 0.5mgml
 1 hydrocortisone. For Bag-1 knockdown, the SCC-13
cell line was transfected with a trio of siRNAs specific for the Bag-1
mRNA (3.33nM each; 10nM total) or with 10nM Silencer control
siRNA at 30% confluence, as described above. At 48h after Bag-1
knockdown, cells were treated with 20mM 5-FU (Sigma-Aldrich)
dissolved in DMSO, or with DMSO only, for 48h.
Measurement of 5-FU-induced apoptosis
Methods for measuring apoptosis based on collection of dead cells
shed into the culture medium have been described previously (Hague
et al, 1993; Dı ´az et al, 2000). In two experiments, western blotting
samples were made from pooled adherent and floating cells. In the
third experiment, cells were used to confirm apoptotic morphology of
the floating cells by staining live cells for 10min with a mixture of
acridine orange and ethidium bromide in PBS, each at 5mgml
 1.
Western blotting
Cells were lysed on ice using RIPA buffer (0.15M NaCl, 1% (v/v)
Nonidet P-40 (NP-40), 0.5% (w/v) sodium deoxycholate, 0.1% (w/v)
SDS, 50mM Tris-HCl (pH 8)) containing protease inhibitors
(Cocktail set III, Calbiochem, Nottingham, UK) and phosphatase
inhibitors (PhosSTOP, Roche, Welwyn Garden City, Hertfordshire,
UK). Lysates were clarified by centrifugation at 15800g for 20min
at 41C. Protein concentration was measured using the BioRad DC
Protein Assay Kit (BioRad Laboratories, Hercules, CA, USA). A
volume containing 60mg protein was loaded onto 7.5% acrylamide
gels for SDS–PAGE. Proteins were transferred to Immobilon-P
polyvinylidene difluoride membrane (Millipore, Consett, County
Durham, UK) by semi-dry electroblotting. Membranes were
blocked for 1h in Milk block buffer (1% 10mM Tris/HCl
(pH7.4), 150mM NaCl, 4% fat free milk powder), and were then
incubated with primary antibody on a rotator at 41C overnight.
Incubation with a-tubulin was carried out at room temperature for
30min. Antibodies used were mouse anti-Bag-1 (G3E2, hybridoma
culture supernatant, gift from G Packham, University of South-
ampton, 1:100), mouse anti-human p53 (clone 1801, hybridoma
culture supernatant, gift of Ann Williams, University of Bristol,
1:100), mouse anti-Hsp70 (SMC-100, StressMarq Biosciences Inc.,
1:10000), mouse anti-a-tubulin (T9026, clone DM1A, Sigma-
Aldrich, 1:10000) and mouse anti-poly-(ADP-ribose) polymerase
(PARP; AM30, Calbiochem, 1:100). After a series of washes in Milk
block buffer and Tween buffer (1% 10mM Tris/HCl (pH7.4), 150mM
NaCl and 0.2% Tween-20) membranes were incubated with HRP-
conjugated sheep anti-mouse secondary antibody (Sigma-Aldrich,
1:1000) for 1h followed by further washes and distilled water rinse.
Peroxidase activity was measured using ECL (Amersham Bio-
sciences, Buckinghamshire, UK) and imaged using Kodak MXB film
(Xograph Imaging Systems, Gloucestershire, UK).
Scoring and data analysis
Two independent investigators (MP and JWE) scored the normal
and tumour sections as no staining (0), weak (þ), moderate
(þþ) or strong (þþþ) for cytoplasmic and nuclear staining
separately. The intensity of the majority of the section was
recorded, as was percentage positivity. In cases of slight
discrepancy, slides were re-examined by the original scorers and
an agreed score was assigned. Statistical analysis was performed
with SPSS software (IBM Corporation, Somers, NY, USA), using
Kruskall–Wallis, Mann–Whitney and Spearman’s r correlation
tests. Tumour and patient characteristics were grouped for
statistical analysis as shown in Table 1.
RESULTS
Bag-1 expression in normal human skin and epidermal
SCC
Bag-1 expression in the epidermis of normal human skin was
found to be primarily nuclear, with expression in the basal and
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ssuprabasal layers and reduced expression towards the upper
epithelial layers, with loss of expression in the cornified layer
(Figures 1A and B). Some scattered nuclei were negative for Bag-1
staining. Negative controls with PBS containing normal goat serum
only or pre-immune rabbit serum showed no staining (Figures 1C
and D, respectively), whereas sweat gland ducts were always
strongly stained and served as a useful internal positive control
(Figure 1E). Lymphocytes, sebaceous glands and the base of the
hair follicles were also consistently strongly stained (data not
shown). As a further control, Bag-1 staining of HaCaT cells
transfected with either Bag-1 siRNA or Silencer control siRNA
were compared after paraffin embedding and sectioning; Bag-1
staining was reduced in the HaCaT cells after Bag-1 knockdown
(Figure 1G) compared with Silencer control-treated cells
(Figure 1F). The extent to which Bag-1 expression was reduced
was investigated by western blotting (Figure 1H). In HaCaT cells
Bag-1S is the predominant isoform, but Bag-1M and Bag-1L are
also expressed. All three Bag-1 protein isoforms are reduced by
siRNA knockdown.
Within the tissue samples of SCC, epithelium adjacent to the
tumours showed a slightly different pattern of Bag-1 expression
compared with normal epidermis, with reduced basal Bag-1
staining (compare Figure 2A with Figure 1B). The adjacent
epithelium was in some cases histologically normal (Figure 2A),
in some cases hyperplastic (Figure 2C) and in some cases
dysplastic (Figure 2E). The intensity of Bag-1 staining was variable
(compare Figures 2A, C and E). Some of the adjacent epithelia
showed evidence of sun damage, including thickened dermal tissue
and deeply penetrating rete pegs (data not shown). Tumours
varied in expression of Bag-1, although some showed pronounced
nuclear and cytoplasmic staining greater than that of the
corresponding adjacent epithelium (compare Figures 2A and B),
others exhibited primarily nuclear staining of similar intensity to
suprabasal cells (compare Figures 2C and D) and some tumours
showed weak or no Bag-1 staining compared with adjacent, non-
invasive epithelium (compare Figures 2E and F). The cytoplasmic
scores for Bag-1 intensity were not significantly different between
the normal tissue samples and the SCC samples (P¼0.272;
Figure 2H), whereas there was a highly significant difference in
nuclear Bag-1 staining between the normal samples and SCC
samples (Po0.001; Figure 2G). The overall picture is of reduced
intensity of nuclear Bag-1 staining in the tumours compared with
normal skin epithelium. However, a subset of tumours showed
moderate to strong Bag-1 staining. The statistical analyses
performed and P-values obtained in this study are summarised
in Table 2.
siRNA
Control
Bag-1L
Bag-1M
Bag-1S
-Tubulin
Bag-1
Figure 1 Bag-1 immunohistochemistry of normal human skin. (A) Bag-1 expression in normal human skin. (B) A higher power image of boxed region in
A, illustrating predominantly nuclear localisation of Bag-1. Negative controls were: (C) negative control tumour section without primary antibody;
corresponding Bag-1 stained tumour showed 80% positive cells (assigned staining intensity scores of nuclear þþþ, cytoplasmic þþ) and (D) rabbit pre-
immune serum; corresponding Bag-1 stained tumour showed 80% positive cells (assigned staining intensity scores of nuclear þþþ, cytoplasmic þþ).
(E) Strong Bag-1 staining in sweat glands was used as an internal positive control to ensure consistent staining. (F, G and H) Validation of Bag-1 TB3
antibody using small interfering RNA (siRNA) knockdown in the HaCaT keratinocyte cell line. HaCaT cells were transfected with Silencer control siRNA( F)
or Bag-1 siRNA (G). (H) Western blot showing reduced expression of Bag-1 protein in HaCaT cells transfected with Bag-1 siRNA compared with Silencer
control siRNA. Images A and E were photographed using a  10 objective (scale bar shown in A), images C, D, F and G were photographed using a  20
objective (scale bars shown in C and F), and image B using a  40 objective (scale bar shown).
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Normal epidermis was generally negative for Hsp70 staining at
the antibody concentration used, with occasional Hsp70-positive
cells located within the basal layer (Figures 3A and B). Indeed,
the majority of SCCs were negative for Hsp70 staining (40/60
tumours; 66.7%; Figure 3D), and there was strong evidence
for reduced Hsp70 staining intensity in the tumours compared
with the normal epidermal samples (Po0.001 and P¼0.015
for nuclear and cytoplasmic Hsp70, respectively). The remaining
33.3% of tumours exhibited weak to moderate cytoplasmic
Hsp70 staining and weak to strong nuclear staining (Figures 3H
and I). Hence, where positive, tumours exhibited both nuclear
and cytoplasmic staining (Figure 3E). Interestingly, the
sun-damaged epithelium adjacent to some of the tumours
showed pronounced Hsp70 staining. In particular, the deep
rete pegs contained strongly Hsp70-positive basal cells
(Figures 3F and G).
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Figure 2 Expression of Bag-1 in epidermal SCC and adjacent epithelium. (A, C and E) Bag-1 expression in epithelium adjacent to SCC; note the altered
pattern of Bag-1 expression in adjacent epithelium, compared with the normal skin expression pattern shown in Figures 1A and B. (B) Moderate to poorly
differentiated SCC showing increased cytoplasmic and nuclear Bag-1 expression relative to adjacent epithelium (A). (D) Well-differentiated SCC showing
reduced cytoplasmic and increased nuclear Bag-1 expression, compared with adjacent epithelium (C). (F) Well-differentiated SCC showing reduced Bag-1
expression relative to adjacent dysplastic epithelium (E). Images C and E were photographed using a  20 objective (scale bar shown in C), and images A,
B, D and F were photographed using a  40 objective (scale bar shown in A). (G) Comparison of intensity of Bag-1 nuclear staining in normal epidermis
compared with the panel of SCCs. (H) Comparison of Bag-1 cytoplasmic staining in normal epidermis compared with the panel of SCCs. Statistical analysis
was performed using a Mann–Whitney test.
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with differentiation of the tumour
Overall, the tumours showed no change in cytoplasmic Bag-1
staining intensity compared with normal epidermal epithelium
(Figure 2H). However, examining the series of tumours further,
there was an inverse association between SCC differentiation and
intensity of cytoplasmic Bag-1 staining in the sections (Po0.001).
These data are illustrated in Figure 4, which shows that well
differentiated tumours tended to have weak or no cytoplasmic
Bag-1 staining, with the intensity of cytoplasmic staining increas-
ing through moderate to poorly differentiated SCC (Figure 4B).
The relationship between differentiation and nuclear Bag-1
staining was less pronounced (P¼0.055). Overall, tumours showed
reduced levels of nuclear Bag-1 compared with normal epidermis
(Figure 2G). Interestingly, although well- and moderately differ-
entiated tumours show reduced nuclear staining compared with
normal epidermis (compare Figure 4A with Figure 2G), the poorly
differentiated tumours tended to show nuclear Bag-1 expression
patterns more similar to those of normal epidermis. This may
reflect an increase in both nuclear and cytoplasmic Bag-1
expression in the poorly differentiated tumours.
The percentage of Bag-1 positive cells in the tumour also showed
an association with differentiation (P¼0.007), indicating a link
between Bag-1 protein and reduced differentiation status. Inter-
estingly, expression of Hsp70 in the tumours also appeared to
show an inverse association with differentiation (Figures 4C, D).
Cytoplasmic Hsp70 staining was inversely associated with tumour
differentiation (P¼0.018; Figure 4D), with nuclear Hsp70 staining
just nonsignificant (P¼0.050; Figure 4C). The percentage of cells
staining positively for Hsp70 also showed an inverse relationship
with the extent of differentiation of the tumour (P¼0.011).
Co-expression of Bag-1 and Hsp70 in epidermal SCC
In serial sections, areas of tumour positive for cytoplasmic Hsp70
tended to exhibit strong cytoplasmic Bag-1 staining (Figure 5) and
there was a clear association between intensity of Hsp70 and Bag-1
staining, with a correlation between cytoplasmic Bag-1 and Hsp70
staining intensity scores (Po0.001; correlation coefficient¼0.462).
There was also a weak correlation between the percentage of cells
that stained positively for Hsp70 in the tumours and the
percentage that were positive for Bag-1 (P¼0.027; correlation
coefficient¼0.286). However, there was no association between
nuclear staining intensities for these two proteins (P¼0.067).
Association between p53-positive staining and nuclear
Bag-1 staining intensity
As it has been reported that p53 gain-of-function mutants
upregulate Bag-1 expression (Yang et al, 1999), 48 of the SCC
sections and 9 sections of normal epidermis were stained for p53.
Normal epidermis was predominantly negative for p53, as p53 is
rapidly degraded in undamaged cells, but occasional p53-positive
cells were seen (1–3%), indicating a damage response (Figures 6A
and B). p53 has been shown to be mutated in 50–90% of human
skin SCC cases (Boukamp, 2005). High levels of p53 are indicative
of p53 protein stabilisation and often indicate presence of a stable
mutant form of p53 in epidermal SCC, although not all p53
mutations are detected as protein by immunohistochemistry
(Brosh and Rotter, 2009). Of the tumours, 87% showed more
extensive nuclear p53-positive staining than normal epidermis
(e.g., Figure 6D). Interestingly, nuclear p53 staining intensity was
associated with nuclear Bag-1 staining intensity (P¼0.042) and the
percentage of cells positive for p53 also correlated with the
percentage of cells positive for Bag-1 (P¼0.003; correlation
coefficient¼0.431; Figure 6 – compare panels E and F with G
and H, respectively; Figure 6I). However, there was no association
between p53 staining and either cytoplasmic Bag-1 staining
intensity or Hsp70 staining.
Bag-1 and Hsp70 expression in epidermal dysplasia and
SCC cell lines compared with normal epidermal
keratinocytes
To ascertain whether high levels of Bag-1 might confer apoptosis
resistance in poorly differentiated SCC, with potential relevance to
treatment, an in vitro model was required. Two human epidermal
dysplasia cell lines (PM1 and PM3) and five epidermal SCC cell
lines (MET2, MET4, SCC-12, SCC-13 and BICR19) were assessed
Table 2 Summary of statistical analysis of Bag-1, Hsp70 and p53 staining in epidermal SCC and normal skin
Comparison Statistical test P-value Significance level Correlation coefficient
Bag-1 staining (n¼60)
Cytoplasmic Bag-1 vs differentiation Kruskal–Wallis o0.001 *** —
Nuclear Bag-1 vs differentiation Kruskal–Wallis 0.055 NS —
Hsp70 staining (n¼60)
Cytoplasmic Hsp70 vs differentiation Kruskal–Wallis 0.018 * —
Nuclear Hsp70 vs differentiation Kruskal–Wallis 0.05 NS —
Bag-1 and Hsp70 staining (n¼60)
Cytoplasmic Bag-1 vs cytoplasmic Hsp70 Spearman’s r o0.001 *** 0.462
Nuclear Bag-1 vs nuclear Hsp70 Spearman’s r 0.067 NS 0.238
p53 staining (n¼48)
% Bag-1 vs % p53 positivity Spearman’s r 0.003 ** 0.431
p53 intensity vs cytoplasmic Bag-1 Kruskal–Wallis 0.47 NS —
p53 intensity vs nuclear Bag-1 Kruskal–Wallis 0.042 * —
Normal epithelium (n¼10) vs skin SCC (n¼60)
Cytoplasmic Bag-1 staining Mann–Whitney 0.272 NS —
Nuclear Bag-1 staining Mann–Whitney o0.001 *** —
Cytoplasmic Hsp70 staining Mann–Whitney 0.015 * —
Nuclear Hsp70 staining Mann–Whitney o0.001 *** —
Abbreviations: Bag-1¼Bcl-2-associated athanogene-1; Hsp70¼heat shock protein-70; NS¼nonsignificant; SCC¼squamous cell carcinoma. *Po0.05; **Po0.01;
***Po0.001.
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keratinocytes. Of these cell lines MET2, SCC-12, SCC-13 and
BICR19 have known p53 mutation and western blotting for p53
(Figure 7) showed the expected levels of p53 – SCC-12 and SCC-13
have higher levels of p53 than normal keratinocytes, and BICR19
does not express the mutant allele and has barely detectable p53
(Burns et al, 1993). MET2 has high levels of p53 consistent with
mutation and similar high levels of p53 were detected in PM1, PM3
and MET4, perhaps indicating mutation outside of exons 5–8 that
were sequenced previously (Popp et al, 2000) or expansion of p53
mutant clones in vitro. As Bag-1 expression was elevated in a
subset of tumours, the hypothesis was that at least some of the SCC
cell lines would express higher levels of Bag-1 than the normal
epidermal keratinocytes and dysplasia cell lines. All of the cell lines
expressed high levels of Bag-1 compared with normal epidermal
keratinocytes (Figure 7), and three SCC cell lines (MET4, SCC-13
and BICR19) showed higher levels of all three Bag-1 protein
isoforms than the PM1 and PM3 dysplasia cell lines. The
predominant isoform was Bag-1S for all of the cell lines. Although
normal keratinocytes showed little or no Hsp70 protein (consistent
with observations in vivo), all of the epidermal dysplasia and
carcinoma cell lines showed increased Hsp70 expression. By
contrast, Hsc70 was expressed at the same levels in all of the cell
lines and the normal keratinocytes.
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Figure 3 Hsp70 immunohistochemistry of normal human skin, epidermal SCC and adjacent epithelium. (A) Normal epidermal epithelium is
predominantly negative for Hsp70 staining, with occasional Hsp70-positive cells, located within the basal layer. A higher power image of the boxed area in A
is shown in B, to highlight the presence of occasional Hsp70-positive cells (arrowheads). (C) Negative control (normal goat serum in PBS) tumour section
without primary antibody; the corresponding Hsp70 stained tumour showed positive staining in 30% of the cells (assigned staining intensity scores of nuclear
þþ, cytoplasmic þ). (D) Tumour negative for Hsp70 staining. (E) Hsp70-positive staining human epidermal SCC. (F and G) Deep peg-like rete ridges
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nuclear staining in normal epithelium and in the panel of SCCs. (I) Intensity of Hsp70 cytoplasmic staining in normal epithelium and in the panel of SCCs.
Images A, F, D and E were photographed using a  10 objective (scale bar shown in A). Images B, C and G were photographed using a  40 objective
(scale bar shown in C). Statistical analysis was performed using a Mann–Whitney test. 0¼undetectable Hsp70 staining; þ¼weak; þþ¼moderate;
þþþ¼strong Hsp70 staining.
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staining; þ¼weak; þþ¼moderate; þþþ¼strong cytoplasmic Bag-1 staining scores.
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enhanced cell growth and apoptosis resistance
The SCC-13 cell line was selected in which to determine the
consequences of Bag-1 knockdown on sensitivity to 5-FU. The
SCC-13 cells were transfected with 10nM of Silencer control siRNA,
or Bag-1 siRNA (a mixture of three Bag-1 siRNA sequences), which
markedly reduced levels of all three Bag-1 isoforms (Figures 8C
and D). Compared with untransfected controls, the Silencer
control siRNA itself did not affect Bag-1 levels (Figure 8C), nor
did it affect the cell yield or apoptotic response to 5-FU (data not
shown). At 48h after siRNA transfection, cultures were treated
with vehicle control (DMSO) or 20mM 5-FU for 48h. Bag-1
knockdown alone reduced the adherent cell yield (Figure 8A) and
increased cell shedding into the culture medium (Figure 8B). The
Bag-1-knockdown cells were more sensitive to 5-FU treatment
than Silencer control-treated cells, demonstrated by a significant
(Po0.001) increase in cell shedding (Figure 8B). The extent of
apoptotic cell shedding in the combination treatment of
Bag-1 knockdown and 5-FU exposure was significantly greater
than the sum of the two independent treatments (Paired t-test,
P¼0.004). Samples were prepared from pooled attached and
floating cells from each treatment condition for western blotting
analysis. Western blotting for PARP was performed as a measure
of apoptotic cell death. There was an increase in the ratio
of cleaved to full-length PARP in 5-FU-treated Bag-1-knockdown
cells compared with 5-FU-treated Silencer control-treated
cells. Examination of the cells by acridine orange and ethidium
bromide staining confirmed that the shed cells were apoptotic
(Figure 8E).
DISCUSSION
To our knowledge, this is the first study of Bag-1 expression in
human epidermal SCC in vivo and the first demonstration that, in
epidermal SCC cells in which Bag-1 is overexpressed, Bag-1 may
contribute to SCC tumour proliferation as well as apoptosis
resistance. Bag-1 expression is deregulated in epidermal SCC
compared with normal epidermis. In our study, Bag-1 in the
normal epidermis is both cytoplasmic and nuclear, as previously
shown by Takayama et al (1998), but the predominant pattern is of
nuclear staining, particularly in the spinous layer. Reduced nuclear
staining intensity compared with normal epithelium is a feature of
most tumours, whereas a subset showed high levels of Bag-1
throughout the cells, particularly noticeable as strong cytoplasmic
staining. These findings are similar to those previously obtained in
our immunohistochemical study of oral SCC (Hague et al, 2002).
In oral SCC, reduced nuclear staining is the predominant pattern
in primary tumours, but lymph node metastases tend to exhibit
strong cytoplasmic staining. Shindoh et al (2000) reported that
small primary oral tumours (T1 and T2) that had associated lymph
node metastases tended to show strong Bag-1 staining. Indeed, Xie
et al (2004) suggested that strong Bag-1 staining may be an
indicator of poor prognosis for tongue SCC, a particularly
aggressive subset of oral cancer.
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Figure 6 p53 staining patterns in normal epidermis and SCC and association with Bag-1 expression. (A and B) p53 expression in normal epidermis.
Normal skin is predominantly negative for p53, with some occasional p53-positive cells. A small number of p53-positive cells can be seen (arrowheads in B).
(C) Negative control tumour section without primary antibody (NGS in PBS alone); (D) corresponding p53 stained section showed 60% of cells p53
positive; assigned a score of þþþnuclear staining. (E) p53 shows strong nuclear staining in skin SCC. (G) Corresponding area of the same tumour
showing moderate nuclear and weak cytoplasmic Bag-1 staining. (F and H) Higher-power images of the boxed areas in images E and G highlight the
presence of predominantly nuclear p53 and Bag-1 staining, respectively. Images A, E and G were photographed using a  10 objective (scale bar shown in
A), images B, D, F and H were photographed using a  40 objective (scale bar shown in B) and image C was photographed using a  20 objective (scale
bar shown). (I) Association between percentage positivity for Bag-1 and p53 in epidermal SCCs. Statistical analysis was performed using a Spearman’s r-test.
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Bcl-2 expression in oral SCC, and Weber et al (2007) found an
association with Bag-1 and Hsp70 in oral SCC. We chose in this
study to address the potential association between Bag-1 and
Hsp70 rather than stain for Bcl-2, because although some studies
have shown an increase in Bcl-2 protein levels in a subset of
epidermal SCC samples (Morales-Ducret et al, 1995; Hussein et al,
2004), the general consensus from recent research suggests that
Bcl-2 is infrequently deregulated in skin SCC (reviewed by Rodust
et al, 2009). The most frequently overexpressed anti-apoptotic
protein of the Bcl-2 family in epidermal SCC reported to date is
Bcl-xL (Delehedde et al, 1999; Vasiljevic et al, 2009). Although
there is no evidence so far that Bag-1 binds other members of the
Bcl-2 family, investigating a potential link between Bag-1 and Bcl-2
and/or Bcl-xL expression in epidermal SCC could be an interesting
future direction of this research.
As Hsp70 is overexpressed in human oral SCC (Kaur et al, 1998),
it was somewhat surprising that the majority of human epidermal
SCCs appeared to be negative for Hsp70 in our study, although this
could reflect the concentration of antibody used. Indeed, all of the
pre-malignant and SCC-derived cell lines expressed Hsp70. This
may reflect in vitro selection of faster growing or apoptosis-
resistant cells, or it could be because of the greater sensitivity of
western blotting compared with immunohistochemistry for
detecting protein expression at the concentration of antibody
used. Interestingly, normal human breast keratinocytes screened
by western blotting also showed low to negative Hsp70 expression,
which corresponds with low to negative Hsp70 expression seen in
normal epidermal epithelium in vivo. However, some Hsp70-
positive areas were detected in normal skin, corresponding with
sun exposure. The Hsp70 expression in keratinocytes may
therefore be related to UV exposure. As our normal keratinocytes
were derived from breast tissue, the lack of sun exposure may
explain this difference in Hsp70 protein expression compared with
the premalignant and SCC cell lines.
The 20/60 epidermal SCC sections that showed strong Hsp70
staining highlighted a subset of tumours with moderate to strong
cytoplasmic Bag-1 expression. This subset of tumours tended to be
classified as exhibiting moderate to poor differentiation. Hsp70 is
induced by UV light exposure and has a role in the response of the
epidermis to damage (Matsuda et al, 2010). We observed patches
of strong Hsp70 staining in epithelium adjacent to skin SCCs, with
particularly strong staining observed in rete pegs. The basal layer
of epidermis adjacent to the tumours frequently showed much
reduced nuclear Bag-1 staining compared with normal epithelium;
however, elevated Bag-1 expression was seen to co-localise with
Hsp70 expression in the rete pegs (data not shown). Matsuda et al
(2010) used an Hsp70 transgenic mouse model to illustrate that
Hsp70 reduces UVB-induced production of pro-inflammatory
cytokines as well as reducing the induction of direct and indirect
DNA damage. Hence, Hsp70 expression may contribute to
protection against tumour development. Hsp70 can also protect
against apoptosis (reviewed by Ja ¨a ¨ttela ¨, 1999) and in the Hsp70
transgenic mouse model, reduced UVB-induced apoptosis is
observed in the epidermis (Matsuda et al, 2010). However, it is
unclear whether this reflects reduced DNA damage, or whether
induction of Hsp70 might permit survival of cells carrying DNA
damage. It is therefore possible that Hsp70 overexpression might
delay tumour formation, but act to promote carcinogenesis at later
stages. Our data suggest that further study is warranted to
address the hypothesis that cytoplasmic Bag-1 and Hsp70
expression together may identify tumours that are more likely to
progress and potentially metastasise, as well as acquire resistance
to chemotherapy.
In the epidermal dysplasia and carcinoma cell lines, Bag-1
protein was overexpressed relative to normal keratinocytes.
In vivo, tumours are heterogeneous for Bag-1 expression and the
intensity scores reflect the majority of the tumour rather than the
maximal intensity of staining. Given that Bag-1 knockdown
reduces the growth and enhances apoptosis of SCC-13 cells
in vitro, it may be that selection for growth in culture has
permitted the survival and expansion of cells within the tumours
with high Bag-1 expression, which may be apoptosis resistant and
have higher proliferative potential. However, the high level of Bag-
1 in the cell lines is not simply adaptation to cell culture, since the
HaCaT immortalised, non-tumourigenic epidermal cell line has
lower levels of Bag-1 than SCC-13 (data not shown). The HaCaT
cell line, which has a UV signature mutation in one p53 allele and
mutation in the other (Lehman et al, 1993), also expresses Hsp70
(data not shown), which as already discussed, may in part be
related to previous UV exposure.
In their study of oral SCC, Xie et al (2004) reported that Bag-1
staining scores showed a positive correlation with Ki67 prolif-
erative index. In our study, Bag-1 knockdown in the epidermal cell
line SCC-13 resulted in induction of apoptosis without 5-FU
treatment. However, Bag-1 knockdown also resulted in a marked
reduction of cell yield that cannot be accounted for by the
induction of apoptosis alone. This suggests that at least in some
epidermal SCC cells, Bag-1 functions to potentiate cell prolifera-
tion as well as apoptosis, and provides support for a potential
functional role for Bag-1 in promotion of cell proliferation in SCC.
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Figure 7 Bag-1 expression in normal epidermal keratinocytes, epidermal
dysplasia and SCC cell lines. Western blot comparing Bag-1, Hsp70, Hsc70
and p53 expression of normal human epidermal keratinocytes (NHK1;
passage 3; two independent sample preparations from the same patient are
shown) with two epidermal dysplasia cell lines (PM1 and PM3) and five
epidermal SCC cell lines (MET2, MET4, SCC-12, SCC-13 and BICR19). All
cell lines were grown on the same culture medium for at least 3 days
before harvest (see Materials and methods). a-Tubulin was used as a
loading control. Asterisks (*) indicate non-specific antibody bands.
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HeLa cervical carcinoma cells inhibited cell growth, and in their
study this led to resistance to anti-cancer drugs, whereas others
have shown that stable knockdown of Bag-1 in HeLa cells
sensitised the cells to cytotoxic drug-induced apoptosis (Xiong
et al 2003). In our study, although Bag-1 reduces cell yield in
SCC-13 cells, the cells are rendered more sensitive to 5-FU-induced
apoptosis.
In summary, our study showed that knockdown of Bag-1 in the
SCC-13 carcinoma cell line enhanced spontaneous apoptosis and
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Figure 8 Bag-1 knockdown in the epidermal SCC cell line SCC-13 decreases cell yield and sensitises to 5-FU-induced apoptosis. Attached (A) and
floating (B) cell counts from SCC-13 cells transfected with 10nM of an irrelevant Silencer control siRNA, or Bag-1 small interfering RNA (siRNA) (a mixture
of three Bag-1 siRNA sequences). Cells were treated 48h after transfection with vehicle control (DMSO) or 20mM 5-FU. Cell counts were performed at
48h post treatment. Data shown are the mean values obtained from three independent experiments, each performed in triplicate. Error bars represent
standard error of the mean. Statistical analysis of attached cell yields and percentage of cells floating indicated a highly significant (Po0.001) difference
between Bag-1 siRNA and Silencer control siRNA under all treatment conditions (analysis of variance and Tukey’s post hoc test). (C) The Bag-1 and Hsp70
levels in SCC-13 cells transfected with 10nM of an irrelevant control siRNA, or Bag-1 siRNA (a mixture of three Bag-1 siRNA sequences). Untransfected
cells treated with oligofectamine alone were included as a control to show that the Silencer control siRNA does not significantly affect basal levels of Bag-1
or Hsp70. Note that Hsp70 levels are unaltered by Bag-1 knockdown. (D) Cleavage of Poly (ADP-ribose) polymerase (PARP) induced by 5-FU is enhanced
subsequent to Bag-1 knockdown. The Hsp70 levels are unaffected by Bag-1 knockdown or by 5-FU treatment. Similar results were obtained in a repeat
experiment. (E) Acridine orange/ethidium bromide staining of Bag-1 siRNA transfected SCC-13 cells treated with 5-FU or vehicle control (DMSO). (a)
Attached cells treated with vehicle control (DMSO). Some occasional spontaneous apoptotic floating cells were seen (inset). (b) Attached cells treated with
5-FU. Note the presence of some apoptotic cells amongst the attached cell population in Bag-1 siRNA-transfected SCC-13 (arrows). (c) Floating cells from
5-FU-treated SCC-13. The majority of cells show classical early apoptotic morphology (condensed chromatin, cell shrinkage, maintenance of membrane
potential; i.e., cells do not take up ethidium bromide and hence appear green). Images a and b were photographed using a  20 objective (scale bar shown
in a). Image c was photographed using a  10 objective (scale bar shown in c). The images have been cropped and enlarged to more clearly show the
floating cells present.
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apoptosis induced by 5-FU in the cells with Bag-1 knockdown was
significantly greater than that induced by either 5-FU alone or
Bag-1 knockdown alone. Continued selection during chemo-
therapy in vivo may potentially result in outgrowth of Bag-1-
overexpressing sub-populations of cells that are resistant to
treatment. It would be of interest to investigate the broader
implications of these findings to determine the extent of Bag-1
overexpression that confers apoptosis resistance to 5-FU, and
perhaps also to alternative treatments such as radiotherapy, using
other cell lines from epidermal dysplasias or carcinomas. Previous
studies have highlighted the importance of the interaction of Bag-1
and Hsp70 in apoptosis resistance (Townsend et al, 2003b, 2004).
Our study indicates co-overexpression of these two proteins in a
subset of tumours and points to a hypothesis that Bag-1 induces
apoptosis resistance in epidermal SCC through a cytoplasmic
Hsp70-dependent mechanism, as in cardiac myocytes (Townsend
et al, 2004). Further investigation of Bag-1 function will be
important, as the Bag-1:Hsp70 complex may be an appropriate
target to sensitise tumour cells to apoptosis-inducing agents and
overcome resistance to chemotherapy.
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